221 related articles for article (PubMed ID: 24283668)
1. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities.
Devhare PB; Steele R; Di Bisceglie AM; Kaplan DE; Ray RB
Gene Expr; 2017 Feb; 17(2):89-98. PubMed ID: 27765085
[TBL] [Abstract][Full Text] [Related]
3. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
4. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.
Chen RX; Song HY; Dong YY; Hu C; Zheng QD; Xue TC; Liu XH; Zhang Y; Chen J; Ren ZG; Liu YK; Cui JF
PLoS One; 2014; 9(3):e88543. PubMed ID: 24614035
[TBL] [Abstract][Full Text] [Related]
6. Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion.
Cao Y; Ding W; Zhang J; Gao Q; Yang H; Cao W; Wang Z; Fang L; Du R
J Proteome Res; 2019 May; 18(5):2032-2044. PubMed ID: 30901224
[TBL] [Abstract][Full Text] [Related]
7. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
[TBL] [Abstract][Full Text] [Related]
11. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
12. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
[TBL] [Abstract][Full Text] [Related]
13. Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.
Negroni L; Taouji S; Arma D; Pallares-Lupon N; Leong K; Beausang LA; Latterich M; Bossé R; Balabaud C; Schmitter JM; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J; Chevet E
Mol Cell Proteomics; 2014 Dec; 13(12):3473-83. PubMed ID: 25225353
[TBL] [Abstract][Full Text] [Related]
14. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
[TBL] [Abstract][Full Text] [Related]
15. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM
PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
[TBL] [Abstract][Full Text] [Related]
20. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
Di Poto C; He S; Varghese RS; Zhao Y; Ferrarini A; Su S; Karabala A; Redi M; Mamo H; Rangnekar AS; Fishbein TM; Kroemer AH; Tadesse MG; Roy R; Sherif ZA; Kumar D; Ressom HW
PLoS One; 2018; 13(3):e0192748. PubMed ID: 29538406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
